Back to methods browser

First-pass extracted concept

CRISPR/Cas9-based gene editing

Candidate: toolkit itemType: engineering method1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

Cas9-based gene editing, CRISPR

Extracted Explainers

What the tool is doing

CRISPR/Cas9-based gene editing is presented as an emerging technology that enables investigation of vascular disease mechanisms.

Source 1DOIPubMed

What problem it solves

It is included as part of the toolkit addressing insufficient mechanistic understanding at the cellular level.

Source 1DOIPubMed

Evidence Snippets

Recent technological innovations, including ... CRISPR/CRISPR-associated protein 9 (Cas9)-based gene editing ... have created new opportunities for investigating the cellular and molecular basis of VDs.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1capabilitysupports2025Source 1DOIPubMed

Single-cell and spatial transcriptomics, super-resolution and photoacoustic imaging, microfluidic organ-on-chip platforms, CRISPR/Cas9-based gene editing, and AI have created new opportunities for investigating the cellular and molecular basis of vascular diseases.

Claim 2capabilitysupports2025Source 1DOIPubMed

These emerging technologies enable high-resolution mapping of cellular heterogeneity and functional alterations, facilitating biomarker discovery, disease modeling, and therapeutic development in vascular diseases.

Claim 3future directionsupports2025Source 1DOIPubMed

Future progress in vascular disease research should prioritize multi-center large-scale validation studies, harmonization of assay protocols, and integration with clinical datasets and human samples.